These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4364172)

  • 21. Vesicular stomatitis viruses resistant to the methylase inhibitor sinefungin upregulate RNA synthesis and reveal mutations that affect mRNA cap methylation.
    Li J; Chorba JS; Whelan SP
    J Virol; 2007 Apr; 81(8):4104-15. PubMed ID: 17301155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. VSV replication in neurons is inhibited by type I IFN at multiple stages of infection.
    Trottier MD; Palian BM; Reiss CS
    Virology; 2005 Mar; 333(2):215-25. PubMed ID: 15721356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiviral activity of the prostanoid clavulone II against vesicular stomatitis virus.
    Bader T; Yamada Y; Ankel H
    Antiviral Res; 1991 Dec; 16(4):341-55. PubMed ID: 1663734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on the antiviral mechanisms of protein kinase inhibitors K-252a and KT5926 against the replication of vesicular stomatitis virus.
    Kim YS; Kawai A
    Biol Pharm Bull; 1998 May; 21(5):498-505. PubMed ID: 9635507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiviral activity of arabinosyladenine and arabinosylhypoxanthine in herpes simplex virus-infected KB cells: selective inhibition of viral deoxyribonucleic acid synthesis in synchronized suspension cultures.
    Shipman C; Smith SH; Carlson RH; Drach JC
    Antimicrob Agents Chemother; 1976 Jan; 9(1):120-7. PubMed ID: 176927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deoxyadenosine antagonism of the antiviral activity of 9-beta-D-arabinofuranosyladenine and 9-beta-D-arabinofuranosylhypoxanthine.
    Smith SH; Shipman C; Drach JC
    Cancer Res; 1978 Jul; 38(7):1916-21. PubMed ID: 207416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. (S)-9-(2,3-Dihydroxypropyl)adenine: an aliphatic nucleoside analog with broad-spectrum antiviral activity.
    De Clercq E; Descamps J; De Somer P; Holý A
    Science; 1978 May; 200(4341):. PubMed ID: 205946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of vesicular stomatitis virus replication by prostaglandin A1 in Aedes albopictus cells.
    Burlandy FM; Ferreira DF; Rebello MA
    Z Naturforsch C J Biosci; 2004; 59(1-2):127-31. PubMed ID: 15018065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory effect of acylphloroglucinol derivatives on the replication of vesicular stomatitis virus.
    Chiba K; Takakuwa T; Tada M; Yoshii T
    Biosci Biotechnol Biochem; 1992 Nov; 56(11):1769-72. PubMed ID: 1369410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiviral activity of arabinosylthymine in herpesviral replication: mechanism of action in vivo and in vitro.
    Aswell JF; Allen GP; Jamieson AT; Campbell DE; Gentry GA
    Antimicrob Agents Chemother; 1977 Aug; 12(2):243-54. PubMed ID: 197886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Streptovirudin inhibits glycosylation and multiplication of vesicular stomatitis virus.
    Kang MS; Park JJ; Singh I; Phillips LA
    Biochem Biophys Res Commun; 1981 Mar; 99(2):422-8. PubMed ID: 6263283
    [No Abstract]   [Full Text] [Related]  

  • 32. Inhibition of vesicular stomatitis virus by kethoxal bis (thiosemicarbazone).
    Levinson W; Oppermann H; Jackson J
    J Gen Virol; 1977 Oct; 37(1):183-90. PubMed ID: 72131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of vesicular stomatitis virus multiplication in Vero cells by 2-deoxy-D-glucose.
    Sabina LR; Telasco CE
    Acta Virol; 1979 May; 23(3):210-20. PubMed ID: 41433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of vesicular stomatitis virus RNA synthesis by 2',3'-dideoxycytidine 5'-triphosphate.
    Patton JT; Davis NL; Wertz GW
    J Gen Virol; 1983 Mar; 64 Pt 3():743-8. PubMed ID: 6298355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of RNA virus replication in vitro by 3-deazacytidine and 3-deazauridine.
    Khare GP; Sidwell RW; Huffman JH; Tolman RL; Robins RK
    Proc Soc Exp Biol Med; 1972 Jul; 140(3):880-4. PubMed ID: 4339065
    [No Abstract]   [Full Text] [Related]  

  • 36. Mechanism of interferon action: inhibition of vesicular stomatitis virus replication in human amnion U cells by cloned human leukocyte interferon. II. Effect on viral macromolecular synthesis.
    Masters PS; Samuel CE
    J Biol Chem; 1983 Oct; 258(19):12026-33. PubMed ID: 6311835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of vesicular stomatitis virus replication by poly(2'-fluoro-2'-deoxyuridylic acid).
    Grosch JC; Erickson RJ
    Antimicrob Agents Chemother; 1975 Nov; 8(5):544-50. PubMed ID: 174488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lauric acid inhibits the maturation of vesicular stomatitis virus.
    Hornung B; Amtmann E; Sauer G
    J Gen Virol; 1994 Feb; 75 ( Pt 2)():353-61. PubMed ID: 8113756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. pppA2'p5A' blocks vesicular stomatitis virus replication in intact cells.
    Alarcon B; Bugany H; Carrasco L
    J Virol; 1984 Oct; 52(1):183-7. PubMed ID: 6090695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergy of 9-beta-D-arabinofuranosyladenine and human interferon against Herpes simplex virus, type 1.
    Lerner AM; Bailey EJ
    J Infect Dis; 1974 Nov; 130(5):549-52. PubMed ID: 4371532
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.